Dan Carlson VIP Pick: LTRN and AI Healthcare Prospects

Dan Carlson of TW Research presents his latest investing idea. Watch now to learn what Dan thinks of Lantern Pharma (LTRN) and their use of AI in healthcare.

TW Research's Disclaimers & Disclosures: TW Research owns stock in Lantern Pharma and has been compensated by Lantern Pharma for research articles on Lantern Pharma. TW Research has not been compensated for production of this video. For a full list of disclaimers and disclosures, please visit
TW Research Group, LLC http://tailwindsresearch.com/disclaimer/.

----------------

Recorded June 20th, 2021. VIP members get exclusive early access to most events including access to the full recordings with the Q&A session. Become a VIP member and view Q&A sessions and exclusive content: https://storytrading.com/vip-upgrade/

Check out StoryTrading here: https://www.storytrading.com/​

You can learn more about TW Research here: https://twresearchgroup.com

You can learn more about LTRN here: https://www.lanternpharma.com/

Disclaimer:
StoryTrading is not a registered investment advisor. Anything said in the video is for informational, educational, and entertainment purposes only and should not be considered as investment advice or a recommendation to invest in any particular security, strategy, or investment product. Investing in securities involves significant risk of loss. Past performance is no indication or guarantee of future results and the value of any investment you make may go up or down.

Visit our website to view our full disclaimer. https://www.storytrading.com/disclaimer/